Distinct roles of immunoreceptor tyrosine‐based motifs in immunosuppressive indoleamine 2,3‐dioxygenase 1

The enzyme indoleamine 2,3‐dioxygenase 1 (IDO1) catalyses the initial, rate‐limiting step in tryptophan (Trp) degradation, resulting in tryptophan starvation and the production of immunoregulatory kynurenines. IDO1's catalytic function has long been considered as the one mechanism responsible f...

Full description

Bibliographic Details
Main Authors: Albini, Elisa, Rosini, Verdiana, Gargaro, Marco, Mondanelli, Giada, Belladonna, Maria L., Pallotta, Maria Teresa, Volpi, Claudia, Fallarino, Francesca, Macchiarulo, Antonio, Antognelli, Cinzia, Bianchi, Roberta, Vacca, Carmine, Puccetti, Paolo, Grohmann, Ursula, Orabona, Ciriana
Format: Online
Language:English
Published: John Wiley and Sons Inc. 2016
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5192792/
id pubmed-5192792
recordtype oai_dc
spelling pubmed-51927922017-01-01 Distinct roles of immunoreceptor tyrosine‐based motifs in immunosuppressive indoleamine 2,3‐dioxygenase 1 Albini, Elisa Rosini, Verdiana Gargaro, Marco Mondanelli, Giada Belladonna, Maria L. Pallotta, Maria Teresa Volpi, Claudia Fallarino, Francesca Macchiarulo, Antonio Antognelli, Cinzia Bianchi, Roberta Vacca, Carmine Puccetti, Paolo Grohmann, Ursula Orabona, Ciriana Original Articles The enzyme indoleamine 2,3‐dioxygenase 1 (IDO1) catalyses the initial, rate‐limiting step in tryptophan (Trp) degradation, resulting in tryptophan starvation and the production of immunoregulatory kynurenines. IDO1's catalytic function has long been considered as the one mechanism responsible for IDO1‐dependent immune suppression by dendritic cells (DCs), which are master regulators of the balance between immunity and tolerance. However, IDO1 also harbours immunoreceptor tyrosine‐based inhibitory motifs, (ITIM1 and ITIM2), that, once phosphorylated, bind protein tyrosine phosphatases, (SHP‐1 and SHP‐2), and thus trigger an immunoregulatory signalling in DCs. This mechanism leads to sustained IDO1 expression, in a feedforward loop, which is particularly important in restraining autoimmunity and chronic inflammation. Yet, under specific conditions requiring that early and protective inflammation be unrelieved, tyrosine‐phosphorylated ITIMs will instead bind the suppressor of cytokine signalling 3 (SOCS3), which drives IDO1 proteasomal degradation and shortens the enzyme half‐life. To dissect any differential roles of the two IDO1's ITIMs, we generated protein mutants by replacing one or both ITIM‐associated tyrosines with phospho‐mimicking glutamic acid residues. Although all mutants lost their enzymic activity, the ITIM1 – but not ITIM2 mutant – did bind SHPs and conferred immunosuppressive effects on DCs, making cells capable of restraining an antigen‐specific response in vivo. Conversely, the ITIM2 mutant would preferentially bind SOCS3, and IDO1's degradation was accelerated. Thus, it is the selective phosphorylation of either ITIM that controls the duration of IDO1 expression and function, in that it dictates whether enhanced tolerogenic signalling or shutdown of IDO1‐dependent events will occur in a local microenvironment. John Wiley and Sons Inc. 2016-09-30 2017-01 /pmc/articles/PMC5192792/ /pubmed/27696702 http://dx.doi.org/10.1111/jcmm.12954 Text en © 2016 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Albini, Elisa
Rosini, Verdiana
Gargaro, Marco
Mondanelli, Giada
Belladonna, Maria L.
Pallotta, Maria Teresa
Volpi, Claudia
Fallarino, Francesca
Macchiarulo, Antonio
Antognelli, Cinzia
Bianchi, Roberta
Vacca, Carmine
Puccetti, Paolo
Grohmann, Ursula
Orabona, Ciriana
spellingShingle Albini, Elisa
Rosini, Verdiana
Gargaro, Marco
Mondanelli, Giada
Belladonna, Maria L.
Pallotta, Maria Teresa
Volpi, Claudia
Fallarino, Francesca
Macchiarulo, Antonio
Antognelli, Cinzia
Bianchi, Roberta
Vacca, Carmine
Puccetti, Paolo
Grohmann, Ursula
Orabona, Ciriana
Distinct roles of immunoreceptor tyrosine‐based motifs in immunosuppressive indoleamine 2,3‐dioxygenase 1
author_facet Albini, Elisa
Rosini, Verdiana
Gargaro, Marco
Mondanelli, Giada
Belladonna, Maria L.
Pallotta, Maria Teresa
Volpi, Claudia
Fallarino, Francesca
Macchiarulo, Antonio
Antognelli, Cinzia
Bianchi, Roberta
Vacca, Carmine
Puccetti, Paolo
Grohmann, Ursula
Orabona, Ciriana
author_sort Albini, Elisa
title Distinct roles of immunoreceptor tyrosine‐based motifs in immunosuppressive indoleamine 2,3‐dioxygenase 1
title_short Distinct roles of immunoreceptor tyrosine‐based motifs in immunosuppressive indoleamine 2,3‐dioxygenase 1
title_full Distinct roles of immunoreceptor tyrosine‐based motifs in immunosuppressive indoleamine 2,3‐dioxygenase 1
title_fullStr Distinct roles of immunoreceptor tyrosine‐based motifs in immunosuppressive indoleamine 2,3‐dioxygenase 1
title_full_unstemmed Distinct roles of immunoreceptor tyrosine‐based motifs in immunosuppressive indoleamine 2,3‐dioxygenase 1
title_sort distinct roles of immunoreceptor tyrosine‐based motifs in immunosuppressive indoleamine 2,3‐dioxygenase 1
description The enzyme indoleamine 2,3‐dioxygenase 1 (IDO1) catalyses the initial, rate‐limiting step in tryptophan (Trp) degradation, resulting in tryptophan starvation and the production of immunoregulatory kynurenines. IDO1's catalytic function has long been considered as the one mechanism responsible for IDO1‐dependent immune suppression by dendritic cells (DCs), which are master regulators of the balance between immunity and tolerance. However, IDO1 also harbours immunoreceptor tyrosine‐based inhibitory motifs, (ITIM1 and ITIM2), that, once phosphorylated, bind protein tyrosine phosphatases, (SHP‐1 and SHP‐2), and thus trigger an immunoregulatory signalling in DCs. This mechanism leads to sustained IDO1 expression, in a feedforward loop, which is particularly important in restraining autoimmunity and chronic inflammation. Yet, under specific conditions requiring that early and protective inflammation be unrelieved, tyrosine‐phosphorylated ITIMs will instead bind the suppressor of cytokine signalling 3 (SOCS3), which drives IDO1 proteasomal degradation and shortens the enzyme half‐life. To dissect any differential roles of the two IDO1's ITIMs, we generated protein mutants by replacing one or both ITIM‐associated tyrosines with phospho‐mimicking glutamic acid residues. Although all mutants lost their enzymic activity, the ITIM1 – but not ITIM2 mutant – did bind SHPs and conferred immunosuppressive effects on DCs, making cells capable of restraining an antigen‐specific response in vivo. Conversely, the ITIM2 mutant would preferentially bind SOCS3, and IDO1's degradation was accelerated. Thus, it is the selective phosphorylation of either ITIM that controls the duration of IDO1 expression and function, in that it dictates whether enhanced tolerogenic signalling or shutdown of IDO1‐dependent events will occur in a local microenvironment.
publisher John Wiley and Sons Inc.
publishDate 2016
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5192792/
_version_ 1613834513068064768